[Black water fever associated with quinine-MP therapy of a malaria patient].
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects* / Q000627:therapeutic use; D001742:Blackwater Fever / Q000139:chemically induced; D004338:Drug Combinations; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000008:administration & dosage; D011803:Quinine / Q000009:adverse effects / Q000627:therapeutic use; D013422:Sulfamonomethoxine / Q000008:administration & dosage
D000962:Antimalarials; D004338:Drug Combinations; D011803:Quinine; D013422:Sulfamonomethoxine; D011739:Pyrimethamine